GCO - Latest News
Genesco Inc. (GCO), operates in Consumer Cyclical / Apparel - Retail, trades on NYSE.
Market capitalization stands near $344.4M. Trailing twelve-month P/E ratio is 24.72. Beta to the broader market is 1.83.
The article list below shows the most recent GCO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent GCO Headlines
Genesco to Report First Quarter Fiscal 2027 Financial Results and Hold Conference Call on May 29, 2026
gurufocus.com - May 15, 2026
Genesco Inc.
Genesco to Report First Quarter Fiscal 2027 Financial Results and Hold Conference Call on May 29, 2026
businesswire.com - May 15, 2026
NASHVILLE, Tenn. --(BUSINESS WIRE)--Genesco to Report First Quarter Fiscal 2027 Financial Results and Hold Conference Call on May 29, 2026.
Genesco: Digital Transformation Is The Shoe That Fits
seekingalpha.com - May 14, 2026
Genesco has found ways to overcome the secular decline in mall traffic and prove that it is fair beyond your typical footwear retailer. With 25% of U
Genesco Names Ashley Randolph Vice President and Chief Accounting Officer
businesswire.com - May 5, 2026
NASHVILLE, Tenn. --(BUSINESS WIRE)--Genesco Inc.
Assenagon Asset Management S.A. Acquires 41,191 Shares of Genesco Inc. $GCO
defenseworld.net - Mar 31, 2026
Assenagon Asset Management S. A.
How News Affects GCO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track GCO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked GCO news questions
- What is the latest GCO news headline?
- The most recent GCO headline (May 15, 2026) is "Genesco to Report First Quarter Fiscal 2027 Financial Results and Hold Conference Call on May 29, 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the GCO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What GCO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual GCO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.